PAM
GBT

Premier Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Premier Asset Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-63,319
Closed -$2.22M – 209
2021
Q2 		$2.22M Buy
63,319
+53,775
+563% +$2.1M 0.33% 46
2021
Q1 		$389K Sell
9,544
-14,192
-60% -$652K 0.07% 150
2020
Q4 		$1.03M Buy
+23,736
New +$1.17M 0.21% 71
2019
Q1 		– Sell
-20,443
Closed -$839K – 149
2018
Q4 		$839K Buy
+20,443
New +$766K 0.23% 66

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Premier Asset Management's GBT Position: Q3 2021 in Review

Premier Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2021, closing a stake of 63,319 shares — an estimated $2.22M sold.

Premier Asset Management first reported a position in GBT in Q4 2018 and held it in 4 quarters. The position peaked at $2.22M in Q2 2021. 187 funds tracked by Wall St. Rank hold GBT as of Q3 2021.

  • Premier Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • Premier Asset Management sold 63,319 Global Blood Therapeutics, Inc. shares in Q3 2021, an estimated $2.22M.
  • Premier Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q4 2018 and held it in 4 quarters.
  • Premier Asset Management's Global Blood Therapeutics, Inc. position peaked at $2.22M in Q2 2021.
  • 187 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2021.

Based on Premier Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.